Kotler Kevin
MELVILLE, NY
$135m in 34 US stocks at the end of 31 December 2025. The top 10 are 81.3% of the money.
Value
$135m
Stocks
34
Top 10 share
81.3%
Turnover
n/a
What changed this quarter
This is the first quarter we have for this fund, so we can't show changes yet.
Holdings
- AngiodynamicsANGO
- Share
- 16.3%
- Value
- $22m
- Shares
- 1,713,789
- Aurinia PharmaceuticalsAUPH
- Share
- 14.4%
- Value
- $20m
- Shares
- 1,224,846
- Avadel PharmaceuticalsAVDL
- Share
- 11.8%
- Value
- $16m
- Shares
- 741,343
- OmerosOMER
- Share
- 11.5%
- Value
- $16m
- Shares
- 905,635
- NeuroPaceNPCE
- Share
- 7.2%
- Value
- $10m
- Shares
- 631,468
- MediWoundMDWD
- Share
- 4.6%
- Value
- $6m
- Shares
- 337,236
- AxogenAXGN
- Share
- 4.1%
- Value
- $5m
- Shares
- 168,000
- Integra Lifesciences HoldingsIART
- Share
- 3.9%
- Value
- $5m
- Shares
- 427,445
- Aclaris TherapeuticsACRS
- Share
- 3.8%
- Value
- $5m
- Shares
- 1,705,929
- Vertical AerospaceEVTL
- Share
- 3.7%
- Value
- $5m
- Shares
- 939,705
- Orasure TechnologiesOSUR
- Share
- 3.2%
- Value
- $4m
- Shares
- 1,801,446
- Lakefront Biotherapeutics NVLKFT
- Share
- 2.2%
- Value
- $3m
- Shares
- 90,000
- Eli LillyLLY
- Share
- 1.6%
- Value
- $2m
- Shares
- 2,000
- CerusCERS
- Share
- 1.5%
- Value
- $2m
- Shares
- 1,011,614
- NikeNKE
- Share
- 1.5%
- Value
- $2m
- Shares
- 32,000
- Tectonic TherapeuticTECX
- Share
- 1.2%
- Value
- $2m
- Shares
- 80,000
- Climb BioCLYM
- Share
- 1.2%
- Value
- $2m
- Shares
- 400,000
- Treace Medical ConceptsTMCI
- Share
- 0.9%
- Value
- $1m
- Shares
- 474,365
- TriSalus Life SciencesTLSI
- Share
- 0.7%
- Value
- $1m
- Shares
- 145,200
- DexcomDXCM
- Share
- 0.7%
- Value
- $995,550
- Shares
- 15,000
- Vanda PharmaceuticalsVNDA
- Share
- 0.7%
- Value
- $882,000
- Shares
- 100,000
- Align TechnologyALGN
- Share
- 0.5%
- Value
- $680,658
- Shares
- 4,359
- OnKure TherapeuticsOKUR
- Share
- 0.4%
- Value
- $573,304
- Shares
- 197,691
- General ElectricGE
- Share
- 0.3%
- Value
- $452,188
- Shares
- 1,468
- PulmonxLUNG
- Share
- 0.3%
- Value
- $442,000
- Shares
- 200,000
- PTC TherapeuticsPTCT
- Share
- 0.3%
- Value
- $379,800
- Shares
- 5,000
- Dycom IndustriesDY
- Share
- 0.3%
- Value
- $355,133
- Shares
- 1,051
- Takeda PharmaceuticalTAK
- Share
- 0.2%
- Value
- $311,800
- Shares
- 20,000
- Beta BionicsBBNX
- Share
- 0.2%
- Value
- $250,342
- Shares
- 8,216
- Ishares TRIHI
- Share
- 0.2%
- Value
- $242,509
- Shares
- 3,902
- Bank of AmericaBAC
- Share
- 0.2%
- Value
- $241,560
- Shares
- 4,392
- Amazon.comAMZN
- Share
- 0.2%
- Value
- $230,820
- Shares
- 1,000
- Elanco Animal HealthELAN
- Share
- 0.2%
- Value
- $205,299
- Shares
- 9,072
- Pliant TherapeuticsPLRX
- Share
- <0.1%
- Value
- $113,460
- Shares
- 93,000
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| AngiodynamicsANGO | 16.3% | $22m | 1,713,789 | |
| Aurinia PharmaceuticalsAUPH | 14.4% | $20m | 1,224,846 | |
| Avadel PharmaceuticalsAVDL | 11.8% | $16m | 741,343 | |
| OmerosOMER | 11.5% | $16m | 905,635 | |
| NeuroPaceNPCE | 7.2% | $10m | 631,468 | |
| MediWoundMDWD | 4.6% | $6m | 337,236 | |
| AxogenAXGN | 4.1% | $5m | 168,000 | |
| Integra Lifesciences HoldingsIART | 3.9% | $5m | 427,445 | |
| Aclaris TherapeuticsACRS | 3.8% | $5m | 1,705,929 | |
| Vertical AerospaceEVTL | 3.7% | $5m | 939,705 | |
| Orasure TechnologiesOSUR | 3.2% | $4m | 1,801,446 | |
| Lakefront Biotherapeutics NVLKFT | 2.2% | $3m | 90,000 | |
| Eli LillyLLY | 1.6% | $2m | 2,000 | |
| CerusCERS | 1.5% | $2m | 1,011,614 | |
| NikeNKE | 1.5% | $2m | 32,000 | |
| Tectonic TherapeuticTECX | 1.2% | $2m | 80,000 | |
| Climb BioCLYM | 1.2% | $2m | 400,000 | |
| Treace Medical ConceptsTMCI | 0.9% | $1m | 474,365 | |
| TriSalus Life SciencesTLSI | 0.7% | $1m | 145,200 | |
| DexcomDXCM | 0.7% | $995,550 | 15,000 | |
| Vanda PharmaceuticalsVNDA | 0.7% | $882,000 | 100,000 | |
| Align TechnologyALGN | 0.5% | $680,658 | 4,359 | |
| OnKure TherapeuticsOKUR | 0.4% | $573,304 | 197,691 | |
| General ElectricGE | 0.3% | $452,188 | 1,468 | |
| PulmonxLUNG | 0.3% | $442,000 | 200,000 | |
| PTC TherapeuticsPTCT | 0.3% | $379,800 | 5,000 | |
| Dycom IndustriesDY | 0.3% | $355,133 | 1,051 | |
| Takeda PharmaceuticalTAK | 0.2% | $311,800 | 20,000 | |
| Beta BionicsBBNX | 0.2% | $250,342 | 8,216 | |
| Ishares TRIHI | 0.2% | $242,509 | 3,902 | |
| Bank of AmericaBAC | 0.2% | $241,560 | 4,392 | |
| Amazon.comAMZN | 0.2% | $230,820 | 1,000 | |
| Elanco Animal HealthELAN | 0.2% | $205,299 | 9,072 | |
| Pliant TherapeuticsPLRX | <0.1% | $113,460 | 93,000 |
Options (4)
- State STR Spdr S&P 500 ETF TSPY
- Type
- Put
- Value
- $239m
- Contracts
- 350,000
- Invesco QQQ TRQQQ
- Type
- Put
- Value
- $31m
- Contracts
- 50,000
- Avadel PharmaceuticalsAVDL
- Type
- Call
- Value
- $19m
- Contracts
- 879,400
- OmerosOMER
- Type
- Call
- Value
- $4m
- Contracts
- 218,700
| Company | Type | Value | Contracts |
|---|---|---|---|
| State STR Spdr S&P 500 ETF TSPY | Put | $239m | 350,000 |
| Invesco QQQ TRQQQ | Put | $31m | 50,000 |
| Avadel PharmaceuticalsAVDL | Call | $19m | 879,400 |
| OmerosOMER | Call | $4m | 218,700 |
Over time and by industry
Value over time
Dec '25
Where the money is
Health care79.5%
Industrials4.3%
Retail & consumer1.7%
Financial services0.2%
Other14.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.